UBS Group AG - CHINA PHARMA HLDGS INC ownership

CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 9 filers reported holding CHINA PHARMA HLDGS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CHINA PHARMA HLDGS INC
ValueSharesWeighting
Q4 2022$7,584
+152.8%
75,838
+505.2%
0.00%
Q2 2022$3,000
-25.0%
12,531
+31.5%
0.00%
Q1 2022$4,000
-63.6%
9,526
-51.2%
0.00%
Q3 2021$11,0000.0%19,519
+26.6%
0.00%
Q2 2021$11,000
+37.5%
15,416
-18.5%
0.00%
Q4 2020$8,000
-55.6%
18,910
-60.6%
0.00%
Q3 2020$18,000
+260.0%
48,018
+516.4%
0.00%
Q2 2020$5,000
-82.1%
7,790
-86.0%
0.00%
Q1 2020$28,000
+180.0%
55,830
+36.2%
0.00%
Q4 2019$10,000
+900.0%
40,991
+858.0%
0.00%
Q3 2019$1,000
-85.7%
4,279
-79.7%
0.00%
Q2 2019$7,000
+600.0%
21,110
+562.0%
0.00%
Q1 2019$1,000
-75.0%
3,189
-79.1%
0.00%
Q4 2018$4,000
+100.0%
15,260
+65.9%
0.00%
Q2 2018$2,000
-66.7%
9,200
-53.4%
0.00%
Q1 2018$6,000
-25.0%
19,728
-57.9%
0.00%
Q4 2017$8,000
+166.7%
46,914
+244.3%
0.00%
Q2 2017$3,000
+200.0%
13,624
+219.7%
0.00%
Q1 2017$1,0004,261
+8422.0%
0.00%
Q4 2016$0
-100.0%
50
-99.4%
0.00%
Q3 2016$2,000
-60.0%
8,137
-72.4%
0.00%
Q1 2016$5,000
+150.0%
29,430
+201.9%
0.00%
Q4 2015$2,000
+100.0%
9,749
+32.1%
0.00%
Q3 2015$1,000
-50.0%
7,378
+31.3%
0.00%
Q4 2014$2,0005,6180.00%
Other shareholders
CHINA PHARMA HLDGS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Virtu Financial LLC 58,693$42,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 195,000$141,0000.00%
HRT FINANCIAL LP 260,918$188,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 28,803$21,0000.00%
MORGAN STANLEY 500$00.00%
Citadel Advisors 46,030$33,0000.00%
Renaissance Technologies 487,479$353,0000.00%
UBS Group AG 15,416$11,0000.00%
View complete list of CHINA PHARMA HLDGS INC shareholders